Clinical Trials in Tennessee

Showing 12721-12740 of 17,345 trials

SENSE Theatre Intervention for Children With Autism Spectrum Disorder (ASD)

NCT02276534

The investigator's goal is to address the need for the development of social interventions for youth with autism in an innovative intervention, SENSE Theatre. The intervention blends established behavioral strategies with theatre techniques that emphasize the involvement of peers, play and performance. The resulting synergy extends promising pilot studies in a randomized group experiment.

Autism Spectrum Disorder

Vanderbilt University136 participantsStarted Aug 2014

Nashville, Tennessee, United States

COMPLETEDPhase 329 miles

A Study of Bevacizumab in Combination With Capecitabine and Cisplatin as First-line Therapy in Patients With Advanced Gastric Cancer

NCT00548548

This study will compare treatment with bevacizumab in combination with capecitabine and cisplatin versus placebo in combination with capecitabine and cisplatin, as first-line therapy in patients with locally advanced or metastatic gastric cancer who had not received prior chemotherapy for advanced or metastatic disease.

Adenocarcinoma

Genentech, Inc.774 participantsStarted Sep 2007

Beverly Hills, California, United States • La Jolla, California, United States • Los Angeles, California, United States +10 more locations

SENSE Theatre Intervention for Children With Autism Spectrum Disorder (ASD)

A Study of Bevacizumab in Combination With Capecitabine and Cisplatin as First-line Therapy in Patients With Advanced Gastric Cancer

Find Trials by Condition in Tennessee

This Was an Open-label, Single-arm Extension Study (CFTY720D2306E1) to a Double-blind, Randomized Multicenter, Placebo-controlled, Parallel-group Core Study (CFTY720D2306) in PPMS.

Serotonin 1A Agonists and Cognition in Schizophrenia

How Your Patients' Non-REM Sleep Changes On Sedatives in the Intensive Care Units

Citrulline in Severe Sepsis

Study to Evaluate the Long-Term Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) in Patients Who Require Opioid Treatment for an Extended Period of Time

Stem Cell Related Donor Safety Study

Safety and Efficacy of Topical Thrombin (Human) Grifols as an Adjunct to Hemostasis During Surgery

A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia

Dose Ranging of GSK2336805 in Combination Therapy

REal World EVidence for TrEAtment of HyperkaLemia in Emergency Department: Multicenter, Prospective, Observational Study

A Feasibility Study of Advance Plasma Therapy001 Plasma/Nitric Oxide Therapy for the Treatment of Diabetic Foot Ulcers

A 2-Part Trial in Subjects With Type 2 Diabetes and in Healthy Subjects to Evaluate GSK1614235, a New Glucose Lowering Drug to Treat Type 2 Diabetes

Covered Metallic Stents for First-Line Treatment of Benign Bile Duct Strictures

A Phase II, Repeat Dose, Proof of Mechanism Study of Losmapimod to Reduce Proteinuria in Patients With Focal Segmental Glomerulosclerosis (FSGS)

Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOX

Efficacy of Prednisone In the Treatment of Ocular Myasthenia

Rollover Protocol Continued Access to Emtricitabine/Tenofovir Disoproxil Fumarate for Adults in United States

Efficacy and Safety of Intravenous to Oral 6-Day Tedizolid Phosphate vs. Intravenous to Oral 10-Day Linezolid in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)